Disphar International BV
Is this your company? Claim this profile
Drug Product
Regulatory, Tech Transfer & Support Services
Company Overview
About
Disphar International BV is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:Netherlands
Founded:1997
Employees:2,278
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
Global
Regulatory Approvals
Drug Approval 6UCQOF
EMA · #APR-V9BDF82L · 2021-12-01
Drug Approval G77ZFD
Health Canada · #APR-SPH5BCM0 · 2021-07-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
Health Canada GMP
Health Canada
Cert #: CERT-DW5CBSYH
Issued: 2020-08-21
Expires: 2025-03-09
WHO GMP
World Health Organization
Cert #: CERT-G9TV6GF9
Issued: 2020-04-05
Expires: 2025-01-02
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-NO9BD8QB
Issued: 2020-01-28
Expires: 2025-07-19
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-6ZT76JUK
Issued: 2020-06-06
Expires: 2025-12-10
Loading CDMO intelligence...
Key facts about Disphar International BV
- Disphar International BV is headquartered in the Netherlands.
- Disphar International BV was founded in 1997.
- Disphar International BV has 2,278 employees.
- Disphar International BV's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like Disphar International BV
Directory pages this company appears in, each with the full list of matching manufacturers.